In orthopaedic care, the precision of imaging is essential for diagnosing conditions, planning surgeries, and evaluating post-operative outcomes. MARS Bioimaging leverages cutting-edge technology to significantly reduce image artifacts, particularly in orthopaedic imaging.
Read More
A clinical trial for the MARS scanner at the Hospital for Special Surgery (HSS) in New York City has been approved to move forward by HSS’ institutional review board (IRB). This study marks the first US clinical trial for the MARS Scanner, set to commence in July 2024.
Read More